Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Brain : a Journal of Neurology|November 26, 2008
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyGilbert Bensimon, Albert Ludolph, Yves Agid, et al.Plos One|September 21, 2011
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United KingdomPaul McCrone, Christine Anne Mary Payan, Martin Knapp, et al.The Lancet. Neurology|March 12, 2018
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging studyTon Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, et al.Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.Expert Opinion on Drug Safety|October 27, 2004
The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosisGilbert Bensimon, Adam DobleEbiomedicine|July 12, 2020
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trialWilliam Camu, Marius Mickunas, Jean-Luc Veyrune, et al.Annals of the New York Academy of Sciences|May 21, 2024
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Clément Bruno, Patrick Emond, et al.International Journal of Palliative Nursing|January 12, 2018
Palliative care in motor neurone diseaseTeresa Fm Barby, P Nigel LeighOrphanet Journal of Rare Diseases|February 5, 2009
Amyotrophic lateral sclerosisLokesh C Wijesekera, P Nigel LeighJournal of Neurology, Neurosurgery, and Psychiatry|March 10, 2011
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityYan Rolland, Marc Vérin, Christine A Payan, et al.Pageof 19